Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 1/20 | 0.49 |
| ▸ | GLP1R | P43220 | 14/20 | 0.49 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.48 |
| ▸ | MC4R | P32245 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30264922 | 1.00 | C5AR1 (0.49) | C5AR1GLP1RIL23RMC4R | |
| SCHEMBL30265020 | 0.95 | GLP1R (0.50) | C5AR1GLP1RIL23RMC4R | |
| SCHEMBL29511132 | 0.94 | GLP1R (0.51) | C5AR1GLP1RMC4R | |
| SCHEMBL30264821 | 0.94 | IL23R (0.52) | IL23RMC4R | |
| SCHEMBL30264908 | 0.92 | C5AR1 (0.50) | C5AR1IL23RMC4R | |
| SCHEMBL30264812 | 0.92 | C5AR1 (0.50) | C5AR1IL23RMC4R | |
| SCHEMBL30264605 | 0.92 | IL23R (0.51) | IL23RMC4R | |
| SCHEMBL30264783 | 0.92 | IL23R (0.51) | IL23RMC4R | |
| SCHEMBL30264745 | 0.92 | IL23R (0.51) | IL23RMC4R | |
| SCHEMBL30264695 | 0.92 | IL23R (0.51) | IL23RMC4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240391954-A1 | MC4R AGONIST PEPTIDES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2024-11-28 | — | — | US | disclosed |
| EP-4392072-A1 | MC4R AGONIST PEPTIDES | The Regents Of The University Of Michigan (US) | 2024-07-03 | — | — | EP | disclosed |
| WO-2023028538-A1 | MC4R AGONIST PEPTIDES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2023-03-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240391954-A1 | MC4R AGONIST PEPTIDES | MC4R, MC3R, MC5R | C5AR1 1506/4885GLP1R 18/4885IL23R 359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.